Effect of Norepinephrine Infusion on Hepatic Blood Flow During Goal-directed Haemodynamic Therapy.

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 28, 2019

Primary Completion Date

October 22, 2020

Study Completion Date

October 14, 2022

Conditions
General Anesthesia
Interventions
DRUG

Norepinephrine

norepinephrine will be started at 0,1 mcg/kg/min and titrated according to its haemodynamic effect. After baseline MAP (which is \> 60 mmHg), norepinephrine is targeted according baseline MAP. At T2, MAP is between 10 - 20 % above baseline (T1), at T3 MAP is between 20 - 30 % above baseline (T1).

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03965117 - Effect of Norepinephrine Infusion on Hepatic Blood Flow During Goal-directed Haemodynamic Therapy. | Biotech Hunter | Biotech Hunter